论文部分内容阅读
目的在治疗椎一基底动脉供血不足性眩晕时,使用倍他司汀加银杏达莫注射液,对其疗效进行观察。方法将2009年4月至2012年10月入住我院的100例患者随机分为两组,治疗组59例,对照组41例。两组首先都采用常规治疗,口服西比灵片、眩晕停片,使用盐酸倍他司汀注射液,7 d为一个疗程;治疗组则在常规治疗基础上,连续7 d加用银杏达莫注射液与倍他司汀之后,对患者阳性体征的变化及眩晕与伴发症状进行观察。结果治疗组在加用银杏达莫注射液与倍他司汀之后效果很好,总有效率为81.4%;对照组相对效果比较慢,总有效率为63.4%。两组对照临床治疗效果,治疗组疗效明显优于对照组疗效,P<0.05,具有统计学意义。结论倍他司汀加银杏达莫注射液对治疗椎一基底动脉供血不足性眩晕效果明显,且比较安全,对人的副作用也比较少,适合应用于临床。
Objective To treat vertebrobasilar artery insufficiency vertigo, the use of Betamethasone plus ginkgo bamo injection, its efficacy was observed. Methods 100 patients admitted to our hospital from April 2009 to October 2012 were randomly divided into two groups: treatment group (59 cases) and control group (41 cases). The first two groups were treated with routine treatment, oral Sibelium tablets, dizzy stop tablets, the use of betipastine hydrochloride injection, 7d for a course of treatment; the treatment group is on the basis of conventional treatment, continuous addition of ginkgo biloba Injection and betiostat, positive signs of changes in patients and dizziness and associated symptoms were observed. Results The treatment group was treated with ginkgo dipyridamole injection and beatostat good effect, the total effective rate was 81.4%; the relative effect of the control group is relatively slow, the total effective rate was 63.4%. Two groups of control clinical effect, the treatment group was significantly better than the control group curative effect, P <0.05, with statistical significance. Conclusion Betatine plus ginkgo biloba injection is effective in treating vertigo-basilar artery insufficiency vertigo. It is safer and has fewer side effects on human. It is suitable for clinical application.